Evelo Biosciences Inc - ESG Rating & Company Profile powered by AI
The assessment of Evelo Biosciences Inc uses data points from across the internet as well as from available documents by Evelo Biosciences Inc. Other corporations in the rating industry group for Evelo Biosciences Inc are shownin the table. The page contains a free Environmental, Social and Governance analysis covering Evelo Biosciences Inc.
Evelo Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 2.0, social score of 4.8 and governance score of 4.8.
3.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 1004 | Xeris Pharmaceuticals Inc | 4.0 | High |
| 1004 | Xenon Pharmaceuticals Inc | 4.0 | High |
| ... | ... | ... | |
| 1089 | Evelo Biosciences Inc | 3.9 | Medium |
| 1089 | Aclaris Therapeutics Inc | 3.9 | Medium |
| 1089 | Allogene Therapeutics Inc | 3.9 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Evelo Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Evelo Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Evelo Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Evelo Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Evelo Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Evelo Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Evelo Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Evelo Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Evelo Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Evelo Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Evelo Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Evelo Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Evelo Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Evelo Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Evelo Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Evelo Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Evelo Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Evelo Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.